Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R First

Showing results (41-50 of 266) with videos related to

Pageof 27
Sort By:
Transplantation Proceedings|February 1, 1995
Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulationsT J Schroeder, S Hariharan, M R First
Transplantation Proceedings|April 1, 1993
Antibody response to OKT3 and methods for monitoringT J Schroeder, S Hariharan, M R First
Transplantation|January 27, 1996
Detection of Epstein-Barr virus message in renal allograftsR M Viero, M R First, T Cavallo
Therapeutic Drug Monitoring|June 13, 2000
Recommendations for bioequivalence testing of cyclosporine generics revisitedU Christians, M R First, L Z Benet
Proceedings of the Clinical Dialysis and Transplant Forum|January 1, 1979
Bw4/Bw6 matching and renal allograft survival in homozygous recipientsW M Spreng, P Nathan, M R First
Transplantation Proceedings|October 1, 1994
Relationship between cyclosporine bioavailability and clinical outcome in renal transplant recipientsT J Schroeder, S Hariharan, M R First
Proceedings of the Clinical Dialysis and Transplant Forum|November 18, 1978
The correlation of kidney transplant survival with lymphocyte mediated cytotoxicity on B cell targetsP Nathan, R T Plessinger, M R First
Archives of Internal Medicine|November 1, 1981
Response to pneumococcal vaccine in renal transplant and hemodialysis patientsC C Linnemann, M R First, G Schiffman
Archives of Internal Medicine|August 1, 1986
Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccineC C Linnemann, M R First, G Schiffman
Transplantation Proceedings|April 1, 1993
OKT3-induced cytokine-release syndrome: renal effects (cytokine nephropathy)M R First, T J Schroeder, S Hariharan
Pageof 27

Showing results (41-50 of 266) with videos related to

Sort By:
Pageof 27
Transplantation Proceedings|February 1, 1995
Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulationsT J Schroeder, S Hariharan, M R First
Transplantation Proceedings|April 1, 1993
Antibody response to OKT3 and methods for monitoringT J Schroeder, S Hariharan, M R First
Transplantation|January 27, 1996
Detection of Epstein-Barr virus message in renal allograftsR M Viero, M R First, T Cavallo
Therapeutic Drug Monitoring|June 13, 2000
Recommendations for bioequivalence testing of cyclosporine generics revisitedU Christians, M R First, L Z Benet
Proceedings of the Clinical Dialysis and Transplant Forum|January 1, 1979
Bw4/Bw6 matching and renal allograft survival in homozygous recipientsW M Spreng, P Nathan, M R First
Transplantation Proceedings|October 1, 1994
Relationship between cyclosporine bioavailability and clinical outcome in renal transplant recipientsT J Schroeder, S Hariharan, M R First
Proceedings of the Clinical Dialysis and Transplant Forum|November 18, 1978
The correlation of kidney transplant survival with lymphocyte mediated cytotoxicity on B cell targetsP Nathan, R T Plessinger, M R First
Archives of Internal Medicine|November 1, 1981
Response to pneumococcal vaccine in renal transplant and hemodialysis patientsC C Linnemann, M R First, G Schiffman
Archives of Internal Medicine|August 1, 1986
Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccineC C Linnemann, M R First, G Schiffman
Transplantation Proceedings|April 1, 1993
OKT3-induced cytokine-release syndrome: renal effects (cytokine nephropathy)M R First, T J Schroeder, S Hariharan
Pageof 27